[1] |
Teitelbaum I. Peritoneal dialysis[J]. N Engl J Med, 2021, 385(19): 1786-1795.
|
[2] |
Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations:2022 update on prevention and treatment[J]. Perit Dial Int, 2022, 42(2): 110-153.
|
[3] |
Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes[J]. Nat Rev Nephrol, 2022, 18(12): 779-793.
doi: 10.1038/s41581-022-00623-7
pmid: 36114414
|
[4] |
Yu D, Cai Y, Chen Y, et al. Development and validation of risk prediction models for cardiovascular mortality in Chinese people initialising peritoneal dialysis: A cohort study[J]. Sci Rep, 2018, 8(1): 1966-1972.
doi: 10.1038/s41598-018-20160-3
pmid: 29386542
|
[5] |
Liyanage T, Ninomiya T, Jha V, et al. Kidney disease: A systematic review[J]. Lancet, 2015, 385(9981):1975-1982.
|
[6] |
Ruiz-Ortega M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease[J]. Nat Rev Nephrol, 2020, 16(5):269-288.
doi: 10.1038/s41581-019-0248-y
pmid: 32060481
|
[7] |
Perl J, Fuller DS, Bieber BA, et al. Peritoneal dialysis-related infection rates and outcomes: Results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS)[J]. Am J Kidney Dis, 2020, 76 (1):42-53.
doi: S0272-6386(19)31105-9
pmid: 31932094
|
[8] |
Cheikh Hassan HI, Murali K, Lonergan M, et al. Association of peritonitis with cardiovascular mortality over time in the peritoneal dialysis population: An Australia and New Zealand dialysis and transplant registry study[J]. Kidney Int Rep, 2022, 7(11):2388-2396.
doi: 10.1016/j.ekir.2022.08.008
pmid: 36531876
|
[9] |
Ye H, Zhou Q, Fan L, et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients[J]. BMC Nephrol, 2017, 18(1):186-193.
doi: 10.1186/s12882-017-0588-4
pmid: 28583107
|
[10] |
Benabed A, Bechade C, Ficheux M, et al. Effect of assistance on peritonitis risk in diabetic patients treated by peritoneal dialysis: Report from the French Language Peritoneal Dialysis Registry[J]. Nephrol Dial Transplant, 2016, 31(4): 656-662.
|
[11] |
高丹, 余沛, 赵子豪, 等. 影响腹膜透析患者发生腹膜炎的相关因素分析[J]. 中国实用内科杂志, 2021, 41(7): 619-623.
|
[12] |
Jensen GL. Malnutrition and inflammation-“burning down the house”: Inflammation as an adaptive physiologic response versus self-destruction?[J]. JPEN J Parenter Enteral Nutr, 2015, 39(1): 56-62.
|
[13] |
Li PK, Chow KM. Infectious complications in dialysis-epidemiology and outcomes[J]. Nat Rev Nephrol, 2011, 8(2):77-88.
|
[14] |
Szeto CC, Wong TY, Chow KM, et al. The clinical course of culture-negative peritonitis complicating peritoneal dialysis[J]. Am J Kidney Dis, 2003, 42( 3) : 567-574.
|
[15] |
Li PK, SzetoCC, PirainoB, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int, 2016, 36(5):481-508.
|
[16] |
Fung WW, Li PK. Recent advances in novel diagnostic testing for peritoneal dialysis-related peritonitis[J]. Kidney Res Clin Pract, 2022, 41( 2) : 156-164.
|
[17] |
Xu R, Yang Z, Qu H, et al. Intraperitoneal vancomycin plus either oral moxifloxacin or intraperitoneal ceftazidime for the treatment of peritoneal dialysis-related peritonitis: A randomized controlled pilot study[J]. Am J Kidney Dis, 2017, 70(1):30-37.
|
[18] |
Liao JL, Zhang YH, Xiong ZB, et al. The association of cognitive impairment with peritoneal dialysis-related peritonitis[J]. Perit Dial Int, 2019, 39(3): 229-235.
|
[19] |
Dong J, Li Z, Xu R, et al. Disease severity score could not predict the outcomes in peritoneal dialysisassociated peritonitis[J]. Nephrol Dial Transplant, 2012, 27(6): 2496-2501.
|
[20] |
Parikova A, Hruba P, Krediet R, et al. Long-term peritoneal dialysis treatment provokes activation ofgenes related to adaptive immunity[J]. Physiol Res, 2019, 68(5): 775-783.
pmid: 31424258
|